# Northern Trust Corp: overview

NTRS · Nasdaq · CIK 73124 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ntrs.md) · [Financials](/companies/ntrs/financials.md) · [Filings](/companies/ntrs/filings.md) · [Insiders](/companies/ntrs/insiders.md)

Latest reported revenue: [$1.37bn](/filings/0000073124-26-000066.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000073124-26-000066).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,222 d](/filings/0000073124-26-000016.md) | [1,214](/filings/0000073124-26-000035.md) | [1,231](/filings/0000073124-26-000047.md) | [1,266](/filings/0000073124-26-000066.md) | [1,307 d](/filings/0000073124-26-000016.md) | [1,341](/filings/0000073124-26-000035.md) | [1,350](/filings/0000073124-26-000047.md) | [1,373](/filings/0000073124-26-000066.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [37.3% d](/filings/0000073124-26-000016.md) | [32.3%](/filings/0000073124-26-000066.md) | [34.2%](/filings/0000073124-26-000066.md) | [36.2%](/filings/0000073124-26-000066.md) | [35.6% d](/filings/0000073124-26-000016.md) | [39.2%](/filings/0000073124-26-000066.md) | [58.7%](/filings/0000073124-26-000066.md) | [46.8%](/filings/0000073124-26-000066.md) |
| Diluted EPS | $ per share | not reported | [1.90](/filings/0000073124-26-000035.md) | [2.13](/filings/0000073124-25-000235.md) | [2.29](/filings/0000073124-25-000247.md) | not reported | [2.71](/filings/0000073124-26-000035.md) | not reported | not reported |
| Free cash flow | $m | [(2,676) d](/filings/0000073124-26-000016.md) | [2,737](/filings/0000073124-26-000035.md) | [1,857 d](/filings/0000073124-26-000047.md) | [509 d](/filings/0000073124-26-000066.md) | [356 d](/filings/0000073124-26-000016.md) | [(329)](/filings/0000073124-26-000035.md) | [(90.3) d](/filings/0000073124-26-000047.md) | [1,803 d](/filings/0000073124-26-000066.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,361](/filings/0000073124-24-000073.md) | [4,433](/filings/0000073124-25-000105.md) | [4,362](/filings/0000073124-26-000016.md) | [4,728](/filings/0000073124-26-000016.md) | [5,018](/filings/0000073124-26-000016.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [35.4%](/filings/0000073124-24-000073.md) | [30.1%](/filings/0000073124-25-000105.md) | [25.4%](/filings/0000073124-26-000016.md) | [43.0%](/filings/0000073124-26-000016.md) | [34.6%](/filings/0000073124-26-000016.md) |
| Diluted EPS | $ per share | [7.14](/filings/0000073124-24-000073.md) | [6.14](/filings/0000073124-25-000105.md) | [5.08](/filings/0000073124-26-000016.md) | [9.77](/filings/0000073124-26-000016.md) | [8.74](/filings/0000073124-26-000016.md) |
| Free cash flow | $m | [1,261](/filings/0000073124-24-000073.md) | [2,264](/filings/0000073124-25-000105.md) | [2,509](/filings/0000073124-26-000016.md) | [(588)](/filings/0000073124-26-000016.md) | [5,460](/filings/0000073124-26-000016.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ntrs/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Levy Susan Cohen](/insiders/1607570.md) | EVP and General Counsel, Officer | Sale (S) | 3,922 | $168.69 | $661.6k | [Form 4](/filings/0001607570-26-000008.md) |
| 2026-10-23 | [Levy Susan Cohen](/insiders/1607570.md) | EVP and General Counsel, Officer | Sale (S) | 16,984 | $168.15 | $2.9m | [Form 4](/filings/0001607570-26-000008.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $2.52bn | 14,517,839 |  | Added +147,984 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.05bn | 11,779,613 |  | Reduced −3,917 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.59bn | 9,095,046 |  | Added +12,298 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.51bn | 8,683,057 |  | Reduced −2,126,833 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.46bn | 8,414,408 |  | Reduced −4,824 |
| [PRIMECAP MANAGEMENT CO/CA/](/funds/763212.md) | 2026-06-30 | $1.06bn | 6,100,742 |  | Reduced −448,295 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $1.01bn | 5,702,539 |  | Reduced −103,177 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $965.6m | 5,554,330 |  | Reduced −322,171 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $892.9m | 5,155,381 |  | Reduced −9,990 |
| [STATE FARM MUTUAL AUTOMOBILE INSURANCE CO](/funds/315032.md) | 2026-06-30 | $720.6m | 4,145,102 |  | Unchanged |

## Recent filings

[All 2,758 filings](/companies/ntrs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:03 ET | [10-Q](/filings/0000073124-26-000066.md) | Quarterly report, period 2026-09-30 | 0000073124-26-000066 |
| 2026-10-21 | 06:39 ET | [8-K](/filings/0000073124-26-000063.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000073124-26-000063 |
| 2026-10-20 | 16:18 ET | [8-K](/filings/0000073124-26-000060.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000073124-26-000060 |
| 2026-09-29 | 17:10 ET | [8-K](/filings/0000073124-26-000057.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000073124-26-000057 |
| 2026-08-03 | 16:58 ET | [8-K](/filings/0000073124-26-000051.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000073124-26-000051 |
| 2026-07-30 | 16:03 ET | [10-Q](/filings/0000073124-26-000047.md) | Quarterly report, period 2026-06-30 | 0000073124-26-000047 |
| 2026-07-22 | 06:52 ET | [8-K](/filings/0000073124-26-000043.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000073124-26-000043 |
| 2026-04-30 | 16:03 ET | [10-Q](/filings/0000073124-26-000035.md) | Quarterly report, period 2026-03-31 | 0000073124-26-000035 |
| 2026-04-22 | 16:08 ET | [8-K](/filings/0000073124-26-000031.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000073124-26-000031 |
| 2026-04-21 | 12:17 ET | [8-K](/filings/0000073124-26-000029.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000073124-26-000029 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000073124-26-000016.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 73124
- Tickers: NTRS, NTRSO
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:40 ET. No prices; not investment advice.